This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
DRAXIMAGE MDP: Affected lot may contain particulate matter
Last updated
Summary
Product
DRAXIMAGE MDP
Issue
Health products - Product quality
What to do
See instructions below.
Audience
Healthcare
Hospitals
Industry
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
DRAXIMAGE MDP |
DRAXIMAGE MDP |
DIN 02329409 |
Powder For Solution |
MEDRONIC ACID 10 MG / VIAL |
1K144 |
Issue
Affected lot may contain particulate matter
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesale, Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs - Radiopharmaceuticals
Companies
JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
16751 Trans Canada Hwy
Kirkland
Quebec
Canada H9H 4J4
Published by
Health Canada
Audience
Healthcare
Hospitals
Industry
Recall class
Type I
Identification number
RA-64521
Get notified
Receive notifications for new and updated recalls and alerts by category.